Joined Today: 0

NVLT Novelos Therapeutics,, Stock Message Board

All Messages

NVLT Message Board Home | Join The NVLT Group |

#12: Novelos Therapeutics
Jason	May 3, 2007 01:13:36 PM
NVLT has plenty of cash with their recent private placement. How will this private placement effet share holders. I have not reviewed any of the terms, but the only way for it to be... view message ignore post recommend post

#11: NVLT News Novelos Therapeutics to Present at MUSC Conference on Cancer Drug Discovery and Development
Stock News Bot	March 15, 2007 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#10: NVLT News Novelos Therapeutics to Present and Webcast at Roth 19th Annual OC Conference
Stock News Bot	February 14, 2007 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#9: NVLT News Novelos Therapeutics and MUSC Submit Two Abstracts for Presentation at AACR 2007 Annual Meeting
Stock News Bot	December 18, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#8: NVLT News Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Novelos Therapeutics, Inc. with a Market Outperform Rating
Stock News Bot	December 15, 2006 08:05:00 AM
NEW YORK--(BUSINESS WIRE)--Rodman & Renshaw, LLC initiated research coverage of Novelos Therapeutics, Inc. (OTC BB: NVLT.OB) with a Market Outperform Rating and an 12-month price... view message ignore post recommend post

#7: NVLT News Novelos Therapeutics CEO Buys 100,000 Shares of NVLT
Stock News Bot	November 9, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#6: NVLT News Novelos Therapeutics Enrolls 1st Patient in Pivotal Phase 3 Lung Cancer Trial
Stock News Bot	November 6, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#5: NVLT News Novelos Therapeutics to Present and Webcast at Rodman & Renshaw 8th Annual Healthcare Conference
Stock News Bot	October 31, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#4: NVLT News Novelos Therapeutics Treatment Proposal for ARS Procurement Bypassed by HHS
Stock News Bot	October 24, 2006 06:00:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#3: NVLT News Novelos Therapeutics Enrolls 1st Patient in Hepatitis C Trial with NOV-205
Stock News Bot	September 28, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#2: NVLT News Novelos Therapeutics to Present at Noble Financial Small Cap Conference
Stock News Bot	September 25, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

#1: NVLT News Novelos Therapeutics Receives Notice of Allowance For 5th U.S. Patent; Further Strengthening Novelos' Commanding IP
Stock News Bot	September 11, 2006 05:30:00 AM
NEWTON, Mass.--(BUSINESS WIRE)--Sept. 11, 2006--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today... view message ignore post recommend post

Group Home | Login if you want to post a message